(Q73382343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Atypical facial pain: a double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

S D Harrison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S A Balawi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Feinmann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Harris

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

83-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

Endogenous pain control mechanisms: Review and hypothesis

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Vascular changes in atypical facial pain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Pain relief by antidepressants: possible modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

The long-term outcome of facial pain treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

The diagnosis and management of psychogenic facial pain disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Psychogenic facial pain: presentation and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Rationale for the use of 5-HT1-like agonists in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Psychogenic aspects of facial pain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

5-Hydroxytryptamine and its role in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Atypical facial pain and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Atypical facial pain syndromes of psychogenic origin; complications of their misdiagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

The history of medical and surgical interests in facial pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

The short-form McGill Pain Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Atypical facial pain: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Atypical facial pain: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Ineffective dental and surgical treatment associated with atypical facial pain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Sumatriptan in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900385-9

7 January 2021

10.1016/S0924-977X(96)00385-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169294%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference